CSPC Pharmaceutical Group Ltd
CSPC Pharmaceutical Group's GHG Emissions Data Preview
In 2023, CSPC Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, CSPC Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into CSPC Pharmaceutical Group's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of CSPC Pharmaceutical Group amounted to 1,081,261 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of CSPC Pharmaceutical Group decreased by 4.91%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
CSPC Pharmaceutical Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are CSPC Pharmaceutical Group's Scope 1 emissions?
In 2023, the total Scope 1 emissions of CSPC Pharmaceutical Group were 663,224 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has CSPC Pharmaceutical Group reduced its Scope 1 emissions over time?
Since 2020, CSPC Pharmaceutical Group's Scope 1 emissions have increased by 90.17%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), CSPC Pharmaceutical Group's Scope 1 emissions increased by 17.5%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are CSPC Pharmaceutical Group's Scope 2 emissions?
In 2023, CSPC Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 418,037 tCOâ‚‚e without specifying the calculation method.
Has CSPC Pharmaceutical Group reduced its Scope 2 emissions over time?
Since 2020, CSPC Pharmaceutical Group's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 40.18%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), CSPC Pharmaceutical Group's Scope 2 emissions (Unspecified Calculation Method) fell by 26.99% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
What methodology does CSPC Pharmaceutical Group use for Scope 2 reporting?
In 2023, CSPC Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology.
CSPC Pharmaceutical Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)